Elevating Ocular Surface Care - Report - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Elevating Ocular Surface Care

  • By

  • Julie Greenbaum, editor

  • Julie Greenbaum, editor

  • May 1, 2026

  • 3 min

Share

Clinical Report: Elevating Ocular Surface Care

Overview

This report discusses the application of Biovance 3L Ocular in treating various ocular surface conditions. Ideal candidates include those with neurotrophic keratitis, non-healing epithelial defects, and moderate to severe dry eye disease.

Background

Ocular surface disorders can significantly impact patient quality of life and vision. Effective management is crucial, particularly for conditions that do not respond to conservative treatments. The use of amniotic membrane therapy, such as Biovance 3L Ocular, offers a promising option for guided epithelial healing.

Data Highlights

No numerical data provided in the source material.

Key Findings

  • Biovance 3L Ocular is indicated for patients needing guided epithelial healing.
  • Ideal candidates include those with neurotrophic keratitis and non-healing epithelial defects.
  • Amniotic membrane therapy is beneficial for persistent epithelial defects and dry eye disease with corneal complications.
  • Proper coding and documentation are essential for reimbursement of amniotic membrane applications.
  • Outcomes of amniotic membrane therapy are influenced by the underlying ocular surface environment.

Clinical Implications

Clinicians should consider Biovance 3L Ocular for patients with specific ocular surface conditions that require enhanced healing. Accurate coding and documentation are vital to ensure reimbursement and support the medical necessity of the treatment.

Conclusion

The integration of Biovance 3L Ocular into treatment protocols can enhance healing in challenging ocular surface cases. Ongoing evaluation of patient outcomes will further define its role in clinical practice.

References

  1. Contact Lens Spectrum, 2013 -- Dry Eye Dx and Tx
  2. Presbyopia Physician, 2023 -- Ocular Surface and Lid Margin Optimization Prior to Refractive Cataract Surgery
  3. Dry Eye Syndrome Preferred Practice Pattern® - Icahn School of Medicine at Mount Sinai
  4. Amniotic membrane transplantation: structural and biological properties, tissue preparation, application and clinical indications | Eye
  5. BIOVANCE® 3L Ocular
  6. Contact Lens Spectrum — Dry Eye Dx and Tx
  7. Contact Lens Spectrum — Managing Ocular Surface Irritation in a Busy Specialty Practice
  8. Dry Eye Syndrome Preferred Practice Pattern® - Icahn School of Medicine at Mount Sinai
  9. Amniotic membrane transplantation: structural and biological properties, tissue preparation, application and clinical indications | Eye
  10. BIOVANCE® 3L Ocular

Original Source(s)

Related Content